EXOG
Nuclease EXOG, mitochondrial
Also known as: ENDOGL1, ENDOGL2, ENGL, ENGL-a, ENGL-b, EXOG_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y2C4
- Gene
- EXOG
- Ensembl
- ENSG00000157036
- Chromosome
- 3
- Canonical length
- 368 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes an endo/exonuclease with 5'-3' exonuclease activity. The encoded enzyme catalyzes the hydrolysis of ester linkages at the 5' end of a nucleic acid chain. This enzyme is localized to the mitochondria and may play a role in programmed cell death. Alternatively spliced transcript variants have been described. A pseudogene exists on chromosome 18. [provided by RefSeq, Feb 2009]
Canonical amino-acid sequenceUniProt
368 residues, UniProt reviewed canonical sequence.
>Q9Y2C4|EXOG
1 MAIKSIASRL RGSRRFLSGF VAGAVVGAAG AGLAALQFFR SQGAEGALTG KQPDGSAEKA
61 VLEQFGFPLT GTEARCYTNH ALSYDQAKRV PRWVLEHISK SKIMGDADRK HCKFKPDPNI
121 PPTFSAFNED YVGSGWSRGH MAPAGNNKFS SKAMAETFYL SNIVPQDFDN NSGYWNRIEM
181 YCRELTERFE DVWVVSGPLT LPQTRGDGKK IVSYQVIGED NVAVPSHLYK VILARRSSVS
241 TEPLALGAFV VPNEAIGFQP QLTEFQVSLQ DLEKLSGLVF FPHLDRTSDI RNICSVDTCK
301 LLDFQEFTLY LSTRKIEGAR SVLRLEKIME NLKNAEIEPD DYFMSRYEKK LEELKAKEQS
361 GTQIRKPSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EXOG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 13 nTPM
- pituitary gland: 6 nTPM
- spleen: 5.8 nTPM
- cerebellum: 5.6 nTPM
- lymph node: 5.6 nTPM
- adrenal gland: 5.2 nTPM
Single-cell type
- cardiomyocytes: 162 nCPM
- myonuclei: 113 nCPM
- pituicytes/fscs: 95 nCPM
- adrenal cortex cells: 90 nCPM
- adrenal medulla cells: 75 nCPM
- lactotrophs: 71 nCPM
Immune cell
- memory B-cell: 61 nTPM
- naive B-cell: 48 nTPM
- NK-cell: 28 nTPM
- gdT-cell: 27 nTPM
- memory CD8 T-cell: 27 nTPM
- naive CD4 T-cell: 26 nTPM
Brain region
- cerebellum: 22 nTPM
- cerebral cortex: 20 nTPM
- white matter: 19 nTPM
- midbrain: 18 nTPM
- hippocampal formation: 18 nTPM
- hypothalamus: 18 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.63
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.41
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- 5'-3' exonuclease activity
- endonuclease activity
- metal ion binding
- nucleic acid binding
- RNA endonuclease activity
- single-stranded DNA endodeoxyribonuclease activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- DNA/RNA non-specific endonuclease/pyrophosphatase/phosphodiesterase domain
- ENPP1-3/EXOG-like, endonuclease/phosphodiesterase domain
- Non-specific endonuclease
- His-Me finger superfamily
- DNA/RNA non-specific endonuclease superfamily
- DNA/RNA non-specific endonuclease
- EXOG, C-terminal
- Endo/exonuclease (EXOG) C-terminal domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EXOG as an antibody target. Whether an autoantibody or antibody against EXOG could matter depends on whether native EXOG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EXOG is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EXOG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...